23andMe, a popular direct-to-consumer genetic testing company, made headlines after its CEO pledged to help reunite the more than 2,300 children separated from their parents at the U.S.’s southern ...

Genetic testing company 23andMe laid off 100 employees on Jan. 23 due to decreasing sales of its direct-to-consumer DNA test kits, CNBC reports. The layoffs, which affect about 14 percent of the ...

23andMe, which sold saliva collection kits to consumers wanting insight into their genetic background, filed for bankruptcy in March 2025. The company has now agreed to sell its data bank to Regeneron ...

When Anne Wojcicki was considering whether she should try to save her life’s work, genetic testing pioneer 23andMe, from bankruptcy last year, many within her inner circle offered the same advice.

Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals’ offer for the DNA-testing company in a bankruptcy auction.

Capping off a dire run of bad news in the last year, 23andMe announced this week that it will be acquired by the pharmaceutical company, Regeneron. While this turn of events might not be the ...

Tarrytown-based Regeneron would acquire 23andMe for $256 million under the deal that is pending approval by bankruptcy court and regulators. New York-based biotech giant Regeneron Pharmaceuticals ...

Anne Wojcicki’s bid to buy 23andMe, the genetic testing company she co-founded nearly 20 years ago, has received the court greenlight. That means Wojcicki’s nonprofit TTAM Research Institute will ...

Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe for $256 million through a bankruptcy auction, the companies said Monday. Regeneron said it will comply with 23andMe’s privacy ...

Direct-to-consumer genetic testing now a booming industry—and it’s easy to see why. A simple swap of the inside of your mouth can provide you with insights into your ethnicity, health, and long-lost ...